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From 2002 through 2005, an outbreak of feline leu-
kemia virus (FeLV) occurred in Florida panthers (Puma 
concolor coryi). Clinical signs included lymphadenopathy, 
anemia, septicemia, and weight loss; 5 panthers died. Not 
associated with FeLV outcome were the genetic heritage 
of the panthers (pure Florida vs. Texas/Florida crosses) 
and co-infection with feline immunodefi ciency virus. Ge-
netic analysis of panther FeLV, designated FeLV-Pco, de-
termined that the outbreak likely came from 1 cross-spe-
cies transmission from a domestic cat. The FeLV-Pco virus 
was closely related to the domestic cat exogenous FeLV-A 
subgroup in lacking recombinant segments derived from 
endogenous FeLV. FeLV-Pco sequences were most similar 
to the well-characterized FeLV-945 strain, which is highly 
virulent and strongly pathogenic in domestic cats because 
of unique long terminal repeat and envelope sequences. 
These unique features may also account for the sever-
ity of the outbreak after cross-species transmission to the 
panther.
The Florida panther (Puma concolor coryi) is the only remaining puma (also called cougar or mountain lion) 
population east of the Mississippi River in North America. 
This population, which is confi ned to a small portion of 
southern Florida, was originally described as 1 of 30 sub-
species of puma (1). By the 1970s, Florida panther numbers 
diminished to ≈30 because of hunting and habitat destruc-
tion. Since the early 1980s, the population has been stud-
ied extensively by monitoring a large proportion of adults 
by radio telemetry (2–5). In the early 1990s, concern over 
the fate of the population increased as signs of inbreeding 
and loss of genetic diversity were reported. These observa-
tions included low levels of genetic variation, high levels 
of sperm abnormalities, and increased incidence of heart 
defects relative to other puma populations and felids in 
general (2,3). In 1995, faced with the compounding ef-
fects of reduced genetic variation, probable depression of 
numbers from inbreeding, and evidence of compromised 
health, wildlife managers released 8 female Texas pumas 
into southern Florida to increase genetic variation and ame-
liorate the physiologic effects of inbreeding. Subsequently, 
increases were noted in the population of individuals of 
mixed genetic heritage, genetic variation, and population 
size; a decrease was noted in incidence of deleterious phys-
iologic traits in crosses between the pure Florida panthers 
and the Texas females (4).
The Florida panther population, as well as other North 
and South American puma populations, has historically 
tested negative for exposure to or infection by feline leuke-
mia viruses (FeLVs). A serosurvey of 38 free-ranging Flor-
ida panthers sampled during 1978–1991 reported complete 
absence of FeLV antigen (3). However, since early 2001, 
23 panthers (>33% of the population) were found to be pos-
itive for FeLV antibodies, and at least 5 adult panthers were 
positive for FeLV antigen and subsequently died. In the 3 
panthers available for necropsy, evidence was found of 
diseases compatible with FeLV infection (5). We describe 
the molecular genetic characterization of circulating FeLV 
strains isolated from the 2001–2005 outbreak and compare 
them with FeLV strains isolated from domestic cats.
FeLV is transmitted horizontally among domestic 
cats through body secretions (6) and was the fi rst retro-
virus shown to cause both neoplastic and degenerative 
disorders (7,8). Like other retroviruses, FeLV induces im-
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munosuppression in its host. Although the mechanism of 
immunopathogenesis is unclear, viral envelope proteins 
may be involved (9). FeLV envelope (env) and the long 
terminal repeat (LTR) sequences have been suggested as 
being involved in determination of disease sequelae, virus 
transactivation, and virus replication (10–12). There are 4 
naturally occurring viral subgroups of exogenous FeLV 
(A, B, C, and T) that are distinguished genetically by se-
quence differences in the env gene and functionally by 
receptor interactions required for cell entry (13). FeLV-A 
is the predominant subgroup circulating in feral cats and 
is often only weakly pathogenic (14). FeLV-B, -C, and -T 
subgroups arise in vivo through recombination between ex-
ogenous FeLV strains and domestic cat endogenous FeLVs 
(8,15). The endogenous feline leukemia provirus sequenc-
es are present in the genome of the domestic cat and are 
transmitted vertically as integral components of the germ-
line (16). Endogenous feline leukemia virus sequences by 
themselves do not produce infectious virus. However, the 
pathogenic subgroups, FeLV-B, -C, and –T, are generated 
by recombination in the env region between exogenous 
subgroup A virus and endogenous proviral sequences (8). 
FeLV-A, -B, -C, and -T are often associated, respectively, 
with thymic lymphoma of T-cell origin (17), tumor forma-
tion (18), aplastic anemia and bone marrow dysfunction 
(17), and lymphoid depletion and immunodefi ciency dis-
ease (13). We used viral genome sequence and phyloge-
netic analyses to identify and characterize the virulent and 
pathogenic FeLV in Florida panthers and compare it with 
FeLV strains in the domestic cat. 
Materials and Methods
Sample Collection and Testing 
Blood and tissue samples were collected from 61 free-
ranging pumas captured during 1988–2004, mainly from 
south Florida. Samples were stored at –70°C and tested for 
FeLV antigen and antibody and for feline immunodefi cien-
cy virus (FIV) by Western blot as described (5) (Figure 1).
PCR Amplifi cation of Proviral DNA 
Genomic DNA was isolated from leukocytes, lymph 
nodes, spleen, intestines, or bone marrow of 61 panthers, 
including all that were positive for FeLV antigen and an-
tibody. Proteinase K digestion was followed by standard 
extraction using the QIAGEN DNeasy tissue DNA extrac-
tion kit (#69504; QIAGEN, Valencia, CA, USA). Isolated 
DNA was visualized by electrophoresis on a 1% agarose gel 
and quantifi ed by using a UV spectrophotometer (Bio-Rad, 
Hercules, CA, USA). PCR primers were designed from the 
conserved regions of env and LTR sequences of domestic cat 
FeLV (GenBank accession nos. M18247, M18248, M12500, 
AY374189, X00188, M14331, M23025, AY364318). PCR 
primers amplifying env (437 bp and 1,700 bp) and env/LTR 
(725 bp) are listed in Figure 2. The forward env/LTR primer 
(LTR4) was designed by using panther FeLV (FeLV-Pco) 
envelope sequence additionally. 
PCR was performed by using ≈50 ng of genomic 
DNA in a 50-μL reaction with 50 mmol/L KCl; 10 mmol/L 
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Figure 1. A) Prevalence and distribution of 19 Florida panthers, 
sampled 1999–2005, showing evidence of feline leukemia virus 
(FeLV) exposure. All antigen-positive panthers (red) are clustered 
in the Okaloacoochee Slough State Forest (O). PCR-positive 
and/or antibody-positive (pink) pumas were found there also, as 
well as in the surrounding areas including Florida Panther National 
Wildlife Refuge (F), private lands (P), Big Cypress Seminole 
Indian Reservation (S), and Big Cypress North and South (BC-N, 
BC-S, respectively). All but 2 infected panthers were found north 
of Interstate 75. B) Information on affected panthers. Gray shading 
indicates timeline for monitoring of individual panthers until death. 
Symbols within gray boxes indicate presence (+), absence (–), or 
no data (*) for FeLV antigen in serum, FeLV sequence recovered by 
PCR, or presence of antibodies against FeLV in serum, respectively.
FP-122 was antigen negative when tested 1 month previously (§). 
LGD ID, Laboratory of Genomic Diversity identifi cation number; FP 
ID, Florida panther identifi cation number; GH, genetic heritage; FIV, 
feline immunodefi ciency virus; GEO, geographic locale; *, missing 
data; gray shading, lifespan of panthers; C, canonical (pure) Florida 
panther; H, Texas hybrid.
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Tris-HCl (pH 8.3); 1.mmol/L MgCl2; 0.25 mmol/L each of 
dATP, dCTP, dGTP, and dTTP; 2 mmol/L of each primer; 
and 2.5 U of Taq Gold polymerase (Applied Biosystems, 
Foster City, CA, USA). PCR was run on a GeneAmp PCR 
system 9700 thermocycler (Applied Biosytems) under the 
following conditions: 9 min 45 s at 95°C; then a touch-
down of annealing temperatures to reduce nonspecifi c am-
plication, always starting with 20 s at 94°C; then 30 s at 
60°C (3 cycles), 58°C (5 cycles), 56°C (5 cycles), 54°C (5 
cycles), 52°C (5 cycles), or 50°C (22 cycles), and then 30 s 
(437-bp env), 1 min (LTR) or 2 min 20 s (1,698-bp env) at 
72°C for extension; and a fi nal extension at 72°C for 7 min. 
PCR products were examined after electrophoresis on a 1% 
agarose gel. Primers and unincorporated deoxynucleotide 
triphosphates were removed by using Microcon YM (Mil-
lipore, Billerica, MA, USA) technology or exonuclease I 
and shrimp alkaline phosphatase (Amersham, Piscataway, 
NJ, USA) (Figure 2). Representative PCR products from 
independent amplifi cations were cloned and sequenced. 
For the env and LTR sequences, products were cloned from 
4 PCR products each (Figure 2). Cloning was performed 
with a TOPO-TA cloning kit (Invitrogen, Carlsbad, CA, 
USA) according to the manufacturer’s instructions. DNA 
was isolated from 6 to 16 clones from each reaction prod-
uct by using a QIAGEN Miniprep Kit. Sequences were ob-
tained from clones by using internal primers in standard 
ABI BigDye terminator (Applied Biosystems) reactions. 
Anticontamination measures were taken at all steps of PCR 
amplifi cation and after PCR processing. Pre-PCR setup 
was performed in a laminar fl ow hood, DNA was added in 
a free-standing containment hood in a separate room, and 
all post-PCR manipulations were performed under a fume 
hood in a third room. All surfaces were washed with a 10% 
bleach solution, and each hood was exposed to UV light for 
30 min before and after use. PCR tubes with individual lids, 
rather than 96-well plates, were used and kept closed ex-
cept when reagents and DNA were being added or aliquots 
were extracted for use. DNA tubes were opened only un-
der their designated hoods; to avoid cross-contamination, 
tubes were never open simultaneously. Water and a sample 
from an FeLV-negative puma were run with every reaction 
as negative controls. Positive controls of known sequence 
were also run for each reaction: 1 from a domestic cat, 1 
from a known seropositive Florida panther (FP-115 or FP-
122), or both.
Phylogenetic Analysis 
Sequences from env and LTR were analyzed sepa-
rately. For analysis relative to known domestic cat FeLV 
sequences, we included FeLV-945, FeLVA-3281, FeLVA-
61E, FeLVA-Glasgow-1, FeLVC-Sarma, FeLVB-Rickard, 
SM-FeSV, enFeLV-AGTT (accession nos. AY662447, 
M18248, M18247, M12500, M14331, X00188, M23025, 
AY364318, respectively) (env) and FCA-945, FCA-934, 
FeLVA-3281, and FeLVA-Glasgow-1 (accession nos. 
AY374189, AY374184, M18248, and M12500, respec-
tively) (LTR). Nucleotide sequences were compiled and 
aligned for subsequent phylogenetic analysis by ClustalX 
(19) and verifi ed visually (20). MODELTEST (21) was 
used for env and LTR analysis to estimate the optimal 
model of sequence evolution; these settings were incorpo-
rated into subsequent analyses. Minimum-evolution trees 
were constructed from models of substitution specifi ed by 
MODELTEST; starting trees were obtained by the neigh-
bor-joining method, followed by application of a tree-bi-
section-reconnection branch-swapping algorithm during a 
heuristic search for the optimal tree. Maximum-parsimony 
analysis used a heuristic search of starting trees obtained 
by stepwise addition and followed by tree-bisection-re-
connection. Maximum likelihood parameters specifi ed by 
MODELTEST selected the general time-reversible model 
of substitution; they included empirical base frequencies 
and estimated rate matrix and corrected for among-site rate 
variation (γ distribution). A bootstrap analysis that used 
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Figure 2. A) Diagram of the feline leukemia 
virus (FeLV) genome showing the PCR 
products obtained from FeLV-Pco env and 
long terminal repeat (LTR) genes. Envelope 
gene surface (SU) and transmembrane 
(TM) subunits, variable regions A and B 
(VRA and VRB) and the proline-rich region 
(PRR), 3’ LTR enhancer element(s) (hatched 
rectangle), signature 21-bp repeat(s) (gray 
shading), and putative c-Myb binding sites 
(black triangles) (12) are depicted for FeLV-
945, FeLV-Pco, and FeLV-3281A . Unique 
signature amino acid residues found only 
in FeLV-945 and FeLV-Pco are marked 
by asterisks (see Figure 5). B) Primer pair 
PfeF6/PfeR6 was designed to detect all FeLV 
subgroups.
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1,000 iterations was performed with each method. Amino 
acid residue alignments were generated by using Mac-
Clade 3.05 (20) and ClustalX. Sequences were inspected 
for homoplasies. Nucleotide sequences were translated to 
protein, and genetic distances were calculated in MEGA 
3.0 (22) by using the Tajima-Nei (nucleotide) and Dayhoff 
(amino acid) algorithms. The sequences of FeLV-Pco env 
and LTR were deposited in GenBank under accession nos. 
EU189489–EU189498.
Results
FeLV Serosurvey and PCR Amplifi cation 
The fi rst sign of an emerging outbreak of FeLV in the 
free-ranging Florida panther population was the 2001 detec-
tion of FeLV antibodies, FeLV proviral PCR, or both, in 8 
pumas from the Florida Panther National Wildlife Refuge, 
private lands, or the northern range of Big Cypress Swamp 
(Figure 1). Antigen-positive results and documented death 
compatible with FeLV infection fi rst occurred in FP-115 in 
2002 near the Okaloacoochee Slough State Forest (5). With 
the exception of FP-108 and FP-119, found in the central 
region of Big Cypress National Park, all 19 other FeLV-ex-
posed panthers were found north of Interstate 75 (Figure 1) 
(5). During the next 2 years, 4 additional antigen-positive 
panthers died; FeLV-related disease was suspected for 2 
(FP-123 and FP-132) and confi rmed for 2 (FP-109 and FP-
122) (5). Additionally, 8 panthers (FP-67, FP-78, FP-82, 
FP-96, FP-99, UCFP43, FP-108, FP-118) that were antigen 
negative but seropositive or PCR positive for FeLV died 
during the outbreak, but their deaths were not attributed to 
FeLV (5). 
Retrospective screening of 6 panthers (FP-67, FP-78, 
FP-82, FP-109, FP-122, FP-132) for antibody or antigen or 
by PCR demonstrated that they had not had FeLV infection 
before this outbreak. FP-96 in the Florida Panther National 
Wildlife Refuge was one of the fi rst to have documented 
FeLV exposure; this panther displayed a latent infection, 
being PCR positive in 2001 and in 2002. Three panthers 
(FP-104, FP-107, FP-119) likely cleared the virus; after 
initial positive test results, they were seronegative on fol-
low-up testing. Positive FIV antibody results by Western 
blot were found for 11 of the 19 FeLV-exposed and 2 of 
the 5 clinically affected panthers (Figure 1). An analysis 
of 21 microsatellites (short tandem repeats) showed that 6 
of the 19 FeLV-exposed and 2 of the 5 antigen-positive 
panthers were crosses with some Texas heritage and that 
the rest were pure Florida panthers (W.E. Johnson et al., 
unpub. data).
Phylogenetic Analysis 
An alignment of FeLV-Pco, FeLV-A, FeLV-B, and 
endogenous env nucleotide sequence (Figure 3) established 
the concordance of FeLV-Pco with subgroup A and found 
a lack of recombination of FeLV-Pco with endogenous 
FeLV-Pco sequence. The absence of endogenous sequenc-
es was not unexpected because pumas and other cats out-
side of the genus Felis do not carry endogenous FeLV se-
quences (23,24). The FeLV-Pco was classifi ed as subgroup 
A on the basis of this lack of evidence for recombination 
with endogenous FeLV across 1,794 bp of FeLV-Pco env 
sequence (Figure 3) and on the basis of in vitro receptor 
utilization studies (5). The aligned sequences of the LTRs 
and the env region were analyzed as separate datasets. For 
both datasets, phylogenetic analyses identifi ed the FeLV-
Pco sequences as monophyletic (Figure 4). Each had strong 
bootstrap support for a clade containing all FeLV-Pco but 
none of the previously sequenced domestic cat FeLVs (Fig-
ure 4). This pattern was consistent with a recent and focal 
introduction of the virus. Furthermore, the 376-bp nucleo-
tide env sequence obtained from the earliest cases of FeLV 
exposure (Pco-972 and Pco-991, found respectively in the 
Florida Panther National Wildlife Reserve and northern 
Big Cypress National Preserve), were identical in sequence 
to the later FeLV cases found in the Okaloacoochee Slough 
State Forest (Figure 2; online Appendix Figure 1, avail-
able from www.cdc.gov/EID/content/14/2/252-appG1.htm). 
On the basis of >50 cloned envelope sequences (Figure 4; 
Table), the FeLV-Pco viruses associated with this outbreak 
were highly conserved. The mean percentage nucleotide 
and amino acid sequence differences of the FeLV env gene 
among FeLV-Pco sequences were 0.4% (nucleotide) and 
0.1% (amino acid). Of published FeLV sequences avail-
able in GenBank, the closest strain was the domestic cat 
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Figure 3. Excerpt of env nucleotide sequences. The shaded regions identify indels where FeLV-Pco sequence resembles that of feline 
leukemia virus A (FeLV-A), ruling out recombination with dissimilar endogenous FeLV sequences as represented in enFeLV-AGTT 
(bottom). Puma sequences, with year of sampling (for example FeLV-Pco-1058-03 was sampled in 2003); domestic cat subgroup A 
(FeLVA-945 and FeLVA-61E), recombinant (FeLVB-GA), and endogenous (enFeLV-AGTT) sequences are also shown. Matches to the 
reference sequence (Pco-1058-02) are indicated by a dot. Gaps are indicated by a dash. Expanded fi gure is available online from www.
cdc.gov/EID/content/14/2/252-G3.htm
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virus FeLV-945, according to LTR and env sequence com-
parisons (Figure 4); calculated differences were only 1.5% 
(nucleotide) and 3.5% (amino acid) between FeLV-Pco 
and FeLV-945 env sequences (Table). 
Because FeLV-945 is well characterized and highly 
virulent in the domestic cat (11,25), sequence elements 
associated with disease determination (env) and transcrip-
tion enhancement (LTR) in FeLV-945 were examined in 
FeLV-Pco. In the envelope protein, 10 signature amino acid 
residues (found within the surface glycoprotein) that were 
shared between FeLV-Pco and FeLV-945 were distinctive 
from other strains of FeLV (Figure 5). Of these synapomor-
phic sites, 2 were in variable region A, which in FeLV-945 
defi nes the specifi city required for viral binding to receptors 
(25). Three of the sites were within the proline-rich region, 
which in FeLV-945 encodes for conformational changes 
required for FeLV cell entry (25). The FeLV-Pco LTR se-
quences had 1 copy of a 40-bp enhancer element that has 
been characterized in FeLV-945 (online Appendix Figure 2, 
available from www.cdc.gov/EID/content/14/2/252-appG2.
htm) (12). Finally, the exogenous domestic cat FeLV-945 
isolate, which FeLV-Pco strains resemble (Figures 4, 5), 
displays unusual repeat junctions where the transcription 
factor c-Myb is known to bind in FeLV-945, possibly accel-
erating the rate of transcription of the virus (Figure 2, online 
Appendix Figure 2) (12). FeLV-Pco also contains 1 copy 
of this repeat junction (Figure 2, panel A; online Appendix 
Figure 2), which supports the conclusion that FeLV-Pco is 
derived from a strain closely related to and perhaps from 
the pathogenic FeLV-945 domestic cat strain. FeLV-945 is 
unusual in that its severe pathogenicity does not involve re-
combination with endogenous FeLV in domestic cats. That 
FeLV-Pco pathogenesis in pumas is due to a virus similar 
to FeLV-945 that was not derived from endogenous recom-
bination is consistent with the complete lack of endogenous 
FeLV sequences in the puma genome. 
Discussion 
We genetically characterized the FeLV that emerged 
in the previously naive free-ranging Florida panther popu-
lation. According to the retrospective longitudinal antibody 
and antigen results and the virus’ geographic distribution, 
the virus was likely introduced into the Florida panther 
population in 2001 (Figure 1) (3). From the earliest detect-
ed panthers with FeLV (2001) to the most recent (2005), 
the FeLV-Pco env sequences were nearly identical, which 
indicates that the source of infection was likely a single 
domestic cat. FP-96, resident in the Florida Panther Na-
tional Wildlife Reserve area in January of 2001, was the 
fi rst panther with exposure detectable by PCR. The virus 
then spread north and east through the population, affect-
ing individual panthers in Big Cypress (FP-100, FP-119), 
Seminole Indian Reservation (FP-118), and Okaloacooch-
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Figure 4. Phylogenetic trees of panther feline leukemia virus (FeLV-
Pco) and domestic cat FeLV nucleotide sequences. A) Midpoint rooted 
maximum-likelihood phylogram based on 1,698 bp of env sequences. 
B) Midpoint rooted maximum-likelihood phylogram based on 463 bp 
of 3’ long terminal repeat (LTR) sequences. Consensus FeLV-Pco 
sequences of clones generated from 5 env and 4 LTR panthers 
and reference domestic cat sequences are shown. The number of 
FeLV-Pco–cloned PCR products used in each consensus sequence 
is indicated in parentheses. The arrow indicates the monophyletic 
clade of all FeLV-Pco sequences. A similar topology, including the 
monophyletic clade, was obtained by using the different FeLV-Pco 
clone sequences rather than a consensus. The year of panther 
sampling is indicated as a suffi x, e.g., Pco-1088-04 was sampled in 
2004. Where maximum-likelihood tree was congruent with maximum 
parsimony tree, branch lengths are indicated below branches. Number 
of homoplasies is indicated after the branch length. Bootstrap values 
are shown (maximum parsimony/minimum evolution/maximum 
likelihood). Asterisk (*) indicates bootstrap value <70. The score (–ln 
likelihood) of the best maximum-likelihood tree was env 3615.01706, 
LTRs 1836.05922 (best tree found by maximum parsimony: env 
length = 221, consistency index [CI] = 0.941, retention index [RI] = 
0.963; LTR length = 132, CI = 0.871, RI = 0.787). 
Characterization of FeLV from Florida Panthers 
ee Slough (FP-109, FP-108, FP-115, FP-122, FP-123, 
FP-132) (Figure 1; online Technical Appendix, available 
from www.cdc.gov/EID/content/14/2/252-Techapp.htm). 
Texas genetic heritage did not protect infected pumas from 
disease associated with FeLV; pure Florida panthers and 
pumas died after having symptoms compatible with FeLV 
(Figure 1). 
Among characterized strains of FeLV, domestic cat 
FeLV-945 was closest in sequence to FeLV-Pco in the pan-
thers. FeLV-945 in domestic cats was originally isolated as 
the predominant FeLV species from a geographic cohort of 
21 infected domestic cats and is known to cause non–T-cell 
diseases characterized by degenerative and proliferative 
changes of myeloid and erythroid origin (26). Although 
FeLV-945 is included among FeLV subgroup A isolates 
on the basis of cell receptor utilization, its distinctive en-
velope and LTR sequence signatures differ from those of 
other FeLV-A strains (25). At the amino-terminal of the 
envelope sequence, the surface glycoprotein, also known as 
gp70, encodes the receptor-binding domain, within which 
are 2 variable regions, A and B. These defi ne the specifi c-
ity required for binding. Further downstream, a proline-rich 
region encodes for the conformational changes required for 
viral entry (25). 
The 10 envelope amino acid residues synapomorphic 
in FeLV-Pco and FeLV-945 included 2 in variable region 
A and 3 in the proline-rich region (Figures 2, 5). In FeLV-
945 LTR, three 21-bp repeats form 2 junctions: 1 junction 
is formed by the fi rst repeat and the adjacent second re-
peat; the other is formed by the second and third repeats. 
Each junction includes a c-Myb binding site that increases 
the rate of viral replication through the recruitment of tran-
scriptional coactivator binding protein (cAMP response el-
ement) (11). FeLV-Pco LTR sequences had 1 copy of the 
repeat junction (Figure 2, online Appendix Figure 2) (12). 
Upstream, LTR transcriptional enhancer elements repeated 
in tandem have been associated with thymic lymphomas 
and are found only in 1 copy in non–T-cell disease (26). 
Like FeLV-945, FeLV-Pco lacks this duplication (Figure 
2, online Appendix Figure 2).
In the panthers, clinical and pathologic fi ndings of 
FeLV-Pco in this outbreak consisted of FeLV-related dis-
eases of non–T-cell origin. These fi ndings are consistent 
with the pathologic changes associated with FeLV-945 in 
the domestic cat. Necropsy fi ndings of FP-115 documented 
interstitial pneumonia, septicemia, and suppurative lymph-
adenopathy. Examination of FP-109 1 month before it died 
found lymphadenopathy, anemia, lymphopenia, and lym-
phoid hyperplasia. FP-122 had similar fi ndings 1 month 
before it died, including lymphadenopathy, muscle wast-
ing, and hypercellular bone marrow with >90% hematopoi-
etic cells. FP-132 necropsy fi ndings included severe pallor 
(indicative of anemia), bronchointerstitial pneumonia, ab-
scesses, lymphadenopathy, and hypercellular bone marrow 
with >90% hematopoietic cells (5). FeLV-Pco is therefore 
similar to the unique and virulent domestic cat strain FeLV-
945 of FeLV subgroup A, in env and LTR sequence and 
in non–T-cell disease outcome. In the domestic cat, FeLV-
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Table. Mean percent amino acid and nucleotide env sequence differences of feline leukemia virus subgroups, FeLV-945, and FeLV-
Pco strains* 
Strain FeLV A† FeLV B‡ FeLV C§ FeLV-945¶ FeLV Pco# 
FeLV A 1.8, 3.8 10.3 6.6 6.4 6.1
FeLV B 19.1 NA 13.2 14 13.3
FeLV C 16.3 28.7 14.2, 6.2 7.3 7.4
FeLV 945 15.2 30.1 16.4 NA 1.5
FeLV Pco 14.3 28.2 16.7 3.5 0.4, 0.1 
*FeLV, feline leukemia virus. Shaded gray boxes contain mean percent sequence differences within strain. Boldface indicates mean percent amino acid 
env sequence differences, 1,689 bp (see Figure 2).  Nucleotide differences are above diagonal. 
†M18247, M18248, M12500, AF052723. 
‡X00188. 
§M14331, M23025 
¶AY374189. 
#Pco-1058-02 (9 cloned sequences), Pco-1058-03 (16 cloned sequences), Pco-1087-04 (17 cloned sequences), Pco-1098-04 (8 cloned sequences). 
Figure 5. Variable sites in the amino acid alignment of panther 
feline leukemia virus (FeLV-Pco) and domestic cat FeLV env 
sequences (1,689 bp). Surface glycoprotein (SU), transmembrane 
(TM), variable region A and B (VRA and VRB), and proline-rich 
region (PRR) locations are indicated. Horizontal line separates 
sequences of puma (above) and domestic cat (below). The 10 
amino acid residues in this region unique to FeLV-945 and FeLV-
Pco sequences are highlighted. Matches to the reference sequence 
are indicated by dots; gaps are indicted by dashes.
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945 causes multicentric lymphoma, myeloproliferative 
disorder, and anemia and has never been associated with 
thymic lymphoma (26). These fi ndings shared between 
FeLV-945 and FeLV-Pco implicate the 10 identifi ed amino 
acid synapomorphies (Figure 5) as plausible determinants 
of disease. Further study of these env regions from T-cell 
and non–T-cell disease manifestations of FeLV occurring 
in comparative felid species is warranted and may eluci-
date the key sequence determinants of disease outcome in 
FeLV.
The role of FIV-related immune suppression, if any, 
in this outbreak is uncertain. Although recent studies of T-
lymphocyte profi les in FIV-infected wild lions and pumas 
suggest that CD4 depletion occurs (27), our survey found 
that co-infection with FIV was present in 2 but absent in 3 
FeLV-associated deaths. FIV-positive panthers could have 
served as a reservoir for the spread of FeLV through the 
population because the earliest detected FeLV-exposed pan-
thers (FP-96 and FP-99) were FIV positive. Furthermore, 
the fi rst panther (FP-115) detected with FeLV-compatible 
disease in the Okaloacoochee Slough State Forest region 
was positive for FIV and FeLV for at least 6 months. 
An FIV serosurvey suggested an overall increase in 
the prevalence of FIV in Florida panthers in recent years. 
During 1999–2000, 3 (15%) of 20 panthers tested had FIV-
positive results by Western blot. In contrast, 13 (76%) of 
17 panthers tested during 2004–2005 in the FeLV-endemic 
Okaloacoochee Slough State Forest  region (Figure 1) were 
FIV positive (5). These results could support a role for 
FIV-mediated immune depletion in FeLV pathogenesis. In 
domestic cats, FIV and FeLV co-infections have resulted 
in confl icting interpretations (28–32). In contrast to FIV, 
which is found in many species of wild felids (33), FeLV 
in nondomestic felids has been reported only a few times, 
in captive cats, with documented or suspected exposure to 
infected domestic cats (5). Serologic survey of free-ranging 
populations found an absence of FeLV in pumas in Cali-
fornia (34), among felids in Botswana (35), and among 38 
free-ranging Florida panthers sampled during 1978–1991 
(3). However, Jessup et al. (36) document a case of FeLV 
in a young adult male free-ranging puma captured from a 
college campus in Sacramento, California. Necropsy of this 
cougar found generalized lymphadenopathy and lymphop-
roliferative disease. These necropsy results are consistent 
with and similar to the clinical fi ndings of the FeLV-posi-
tive panthers reported here.
The outbreak of FeLV in the previously naive popula-
tion of endangered Florida panthers raised questions about 
management of free-ranging pumas. In response, the Florida 
Department of Fisheries and Wildlife began a widespread 
vaccination program of Florida panthers; no additional 
FeLV cases have since been detected among them (5). 
This emerging disease outbreak was characterized by 
2 factors. First, because of its unique heritage and popular-
ity, the Florida panther has been the most intensively moni-
tored wild felid in North America. Second, the extensive 
veterinary surveillance of the domestic cat has provided 
powerful models for studying infectious diseases relevant 
to understanding human health and disease, including ret-
roviruses such as FeLV (37). Although future cross-species 
transmission events among wild and domestic carnivore 
populations may be unavoidable, our understanding of 
pathogen and host genetic determinants may also be greatly 
enhanced by the recent release of the genome sequence of 
the domestic cat (38). Combining progress in biomedical 
genomics with intensive studies of wild species can pro-
vide insights into emerging pathogens that affect wild, do-
mestic, and human hosts.
Acknowledgments
We thank Jill Slattery for help with data analysis, Jan Mar-
tenson and Melody Roelke for help with sample database manage-
ment and background information about the Florida panther study 
population, and Meghan Kessler for assistance in the laboratory. 
We dedicate this article to Murry Gardner, who originally 
uncovered the FeLV-945 isolates in California and whose accom-
plishments and career as a retrovirology pioneer have inspired 
generations of veterinary scientists.
Samples were collected in full compliance with specifi c fed-
eral permits (Convention on International Trade in Endangered 
Species; Endangered and Threatened Species) issued to the Na-
tional Cancer Institute by the US Fish and Wildlife Service of the 
Department of the Interior. 
This project was funded in part with federal funds from the 
National Cancer Institute, National Institutes of Health, under 
contract N01-CO-12400. This research was supported in part by 
the Intramural Research Program of the National Institutes of 
Health, National Cancer Institute, Center for Cancer Research.
Dr Brown is a veterinarian and a PhD candidate research fel-
low in the Laboratory of Genomic Diversity at the National Can-
cer Institute in Frederick, Maryland. Her primary research inter-
ests include molecular genetic determinants of viral pathogenesis 
in the cat model.
References
  1.  Culver M, Johnson WE, Pecon-Slattery J, O’Brien SJ. Genom-
ic ancestry of the American puma (Puma concolor). J Hered. 
2000;91:186–97.
  2.  Roelke, ME, Martenson, JS, O’Brien, SJ. The consequences of de-
mographic reduction and genetic depletion in the endangered Flori-
da panther. Curr Biol. 1993:3:340–50.
  3.  Roelke ME, Forrester DJ, Jacobson ER, Kollias GV, Scott FW, Barr 
MC, et al. Seroprevalence of infectious disease agents in free-rang-
ing Florida panthers (Felis concolor coryi). J Wildl Dis. 1993;29:
36–49.
258 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 14, No. 2, February 2008
Characterization of FeLV from Florida Panthers 
  4.  Maehr DS, Lacy R. Avoiding the lurking pitfalls in Florida panther 
recovery. Wild Soc Bull. 2002;30:971–8.
  5.  Cunningham MW, Brown MA, Shindle DB, Terrell SP, Hayes KA, 
Ferree BC, et al. Epizootiology and management of feline leukemia 
virus in the Florida puma. J Wildl Dis. In press. 
  6.  Hardy WD Jr, Old LJ, Hess PW, Essex M, Cotter S. Horizontal 
transmission of feline leukaemia virus. Nature. 1973;244:266–9.
  7.  Jarrett WF, Crawford EM, Martin WB, Davie F. A virus-like par-
ticle associated with leukemia (lymphosarcoma). Nature. 1964;202:
567–9.
  8.  Mullins JI, Hoover EA. Molecular aspects of feline leukemia virus 
pathogenesis. In: Gallo RC, Wong-Staal F, editors. Retrovirus biol-
ogy and human disease. New York: Dekker; 1990. p. 87–116.
  9.  Denner J. How does HIV induce AIDS? The virus protein hypoth-
esis. J Hum Virol. 2000;3:81–2.
10.  Abujamra AL, Faller DV, Ghosh SK. Mutations that abrogate trans-
activational activity of the feline leukemia virus long terminal repeat 
do not affect virus replication. Virology. 2003;309:294–305.
11.  Chandhasin C, Coan PN, Pandrea I, Grant CK, Lobelle-Rich PA, Pu-
etter A, et al. Unique long terminal repeat and surface glycoprotein 
gene sequences of feline leukemia virus as determinants of disease 
outcome. J Virol. 2005;79:5278–87.
12.  Finstad SL, Prabhu S, Rulli KR, Levy LS. Regulation of FeLV-
945 by c-Myb binding and CBP recruitment to the LTR. Virol J. 
2004;1:3.
13.  Overbaugh J, Bangham CR. Selection forces and constraints on ret-
roviral sequence variation. Science. 2001;292:1106–9.
14.  Phipps AJ, Hayes KA, Al-dubaib M, Roy-Burman P, Mathes LE. 
Inhibition of feline leukemia virus subgroup A infection by coinocu-
lation with subgroup B. Virology. 2000;277:40–7.
15.  Stewart MA, Warnock M, Wheeler A, Wilkie N, Mullins JI, On-
ions DE, et al. Nucleotide sequences of a feline leukemia virus sub-
group A envelope gene and long terminal repeat and evidence for 
the recombinational origin of subgroup B viruses. J Virol. 1986;58:
825–34.
16.  Okabe H, Twiddy E, Gilden RV, Hatanaka M, Hoover EA, Olsen 
RG. FeLV-related sequences in DNA from a FeLV-free cat colony. 
Virology. 1976;69:798–801.
17.  Neil JC, Fulton R, Rigby M, Stewart M. Feline leukaemia virus: 
generation of pathogenic and oncogenic variants. Curr Top Micro-
biol Immunol. 1991;171:67–93.
18.  Donahue PR, Quackenbush SL, Gallo MV, deNoronha CM, Over-
baugh J, Hoover EA, et al. Viral genetic determinants of T-cell kill-
ing and immunodefi ciency disease induction by the feline leukemia 
virus FeLV-FAIDS. J Virol. 1991;65:4461–9.
19.  Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG. 
The CLUSTAL X windows interface: fl exible strategies for multiple 
sequence alignment aided by quality analysis tools. Nucleic Acids 
Res. 1997;25:4876–82.
20.  Maddison DR, Maddison WP. MacClade 3.05. Sunderland (MA): 
Sinauer Associates; 1995.
21.  Posada D, Crandall KA. MODELTEST: testing the model of DNA 
substitution. Bioinformatics 1998;14:817–8.
22.  Kumar S, Tamura K, Nei M. MEGA3: Integrated software for mo-
lecular evolutionary genetics analysis and sequence alignment. Brief 
Bioinform. 2004;5:150–63.
23.  Benveniste RE, Todaro GJ. Segregation of RD-114 and FeLV-related 
sequences in crosses between domestic cat and leopard cat. Nature. 
1975;257:506–8.
24.  Reeves RH, O’Brien SJ. Molecular genetic characterization of the 
RD-114 gene family of endogenous feline retroviral sequences. J 
Virol. 1984;52:164–71.
25.  Chandhasin C, Coan PN, Levy LS. Subtle mutational changes in the 
SU protein of a natural feline leukemia virus subgroup A isolate alter 
disease spectrum. J Virol. 2005;79:1351–60.
26.  Chandhasin C, Lobelle-Rich P, Levy LS. Feline leukaemia virus 
LTR variation and disease association in a geographical and tempo-
ral cluster. J Gen Virol. 2004;85:2937–42.
27.  Roelke ME, Pecon-Slattery J, Taylor S, Citino S, Brown E, Packer 
C, et al. T-lymphocyte profi les in FIV-infected wild lions and pumas 
reveal CD4 depletion. J Wildl Dis. 2006;42:234–48.
28.  Cohen ND, Carter CN, Thomas MA, Lester TL, Eugster AK. Epizo-
otiologic association between feline immunodefi ciency virus infec-
tion and feline leukemia virus seropositivity. J Am Vet Med Assoc. 
1990;197:220–5.
29.  Ishida T, Washizu T, Toriyabe K, Motoyoshi S, Tomoda I, Pedersen 
NC. Feline immunodefi ciency virus infection in cats of Japan. J Am 
Vet Med Assoc. 1989;194:221–5.
30.  Lee IT, Levy JK, Gorman SP, Crawford PC, Slater MR. Prevalence 
of feline leukemia virus infection and serum antibodies against fe-
line immunodefi ciency virus in unowned free-roaming cats. J Am 
Vet Med Assoc. 2002;220:620–2.
31.  O’Connor TP Jr, Tonelli QJ, Scarlett JM. Report of the National 
FeLV/FIV Awareness Project. J Am Vet Med Assoc. 1991;199:
1348–53.
32.  Yamamoto JK, Hansen H, Ho EW, Morishita TY, Okuda T, Sawa 
TR, et al. Epidemiologic and clinical aspects of feline immunodefi -
ciency virus infection in cats from the continental United States and 
Canada and possible mode of transmission. J Am Vet Med Assoc. 
1989;194:213–20.
33.  Troyer JL, Pecon-Slattery J, Roelke ME, Johnson W, VandeWoude 
S, Vazquez-Salat N, et al. Seroprevalence and genomic divergence 
of circulating strains of feline immunodefi ciency virus among Feli-
dae and Hyaenidae species. J Virol. 2005;79:8282–94.
34.  Paul-Murphy J, Work T, Hunter D, McFie E, Fjelline D. Sero-
logic survey and serum biochemical reference ranges of the free-
ranging mountain lion (Felis concolor) in California. J Wildl Dis. 
1994;30:205–15.
35.  Osofsky SA, Hirsch KJ, Zuckerman EE, Hardy WD. Feline lentivi-
rus and feline oncovirus status of free-ranging lions (Panthera leo), 
leopards (Panthera pardus), and cheetahs (Acinonyx jubatus) in Bo-
tswana: a regional perspective. J Zoo Wildl Med. 1996;27:453–67.
36.  Jessup D. Feline leukemia virus infection and renal spirochetosis in 
a free-ranging cougar (Felis concolor). J Zoo Wildl Med. 1993;24:
73–9.
37.  Roelke ME, Martenson JS, O’Brien SJ. The consequences of demo-
graphic reduction and genetic depletion in the endangered Florida 
panther. Curr Biol. 1993;3:340–50.
38.  Pontius JU, Mullikin JC, Smith DR, Agencourt Sequencing Team, 
Lindblad-Toh K, Gnerre S, et al. Initial sequence and comparative 
analysis of the cat genome. Genome Res. 2007 17:1675–89.
Address for correspondence: Stephen J. O’Brien, NCI-Frederick, Bldg 
560, Rm 11-82, Frederick, MD 21702-1201, USA; email: obrien@ncifcrf.
gov
 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 14, No. 2, February 2008 259 
Search past issues of EID at www.cdc.gov/eid
